HANNAH SINCLAIR: Open Payments
NPI 1437773967 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,407 in 158 payments from 23 companies in 2025. Trend: 2023 $1,621 · 2024 $3,221 · 2025 $3,407
Food & beverage: $3,407
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 31 | $615 |
| AstraZeneca Pharmaceuticals LP | 13 | $373 |
| GENZYME CORPORATION | 8 | $366 |
| Insmed, Inc. | 12 | $280 |
| Amgen Inc. | 19 | $280 |
| Verona Pharma, Inc. | 9 | $220 |
| Mallinckrodt Hospital Products Inc. | 5 | $159 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $158 |
| Inspire Medical Systems, Inc. | 12 | $137 |
| Baxter Healthcare | 6 | $131 |
Products named: DUPIXENT, NUCALA, Arikayce, TEZSPIRE, TRELEGY ELLIPTA, Ohtuvayre, AIRSUPRA, ACTHAR.
Industry payments across KY — which companies pay providers there.
